Premature Ejaculation (PE) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032


 In the male reproductive system, ejaculation refers to the release and external expression of semen. Premature ejaculation is a term used to describe the occurrence of ejaculation happening consistently earlier than desired by a man or his partner during sexual activity. This condition is recognized as the most prevalent male sexual disorder. Primarily of psychological origin, premature ejaculation's precise cause remains largely unknown. Various contributing risk factors have been identified, encompassing biological and psychological aspects. Biological factors include abnormal levels of the brain neurotransmitter serotonin, abnormal hormonal levels, hypogonadism, inflammation or infection of the prostate or urethra, and erectile dysfunction. Psychological factors include depression, anxiety, stress, guilt, narcissism, distorted thinking, unrealistic expectations about sexual performance, performance anxiety, history of sexual repression, overall lack of confidence or poor body image, and history of sexual abuse or prior negative experiences. The control of ejaculation is regulated by the spinal ejaculatory generator center, located at the L1-L2 level. This center receives inputs from the penile nerves, both parasympathetic and sympathetic, and communicates through sensory and motor nerves. Alongside the spinal ejaculatory center, the central, spinal, and peripheral nervous systems collaboratively function for emission and ejaculation. A normal ejaculation is a complex but well-coordinated sequence of physiological events involving three phases: emission, expulsion, and orgasm. Before diagnosing premature ejaculation, other conditions must be considered, such as severely delayed orgasm in the female partner. The average time to reach climax in females is 12 to 25 minutes. In cases of extremely delayed female orgasm, almost any male would be perceived as experiencing premature ejaculation, making the partner's sexual response a factor that necessitates evaluation. Common treatment options for premature ejaculation include behavioral techniques, medications, and counseling. Topical applications such as creams, gels, or sprays containing numbing agents like benzocaine, lidocaine, or prilocaine are used to alleviate premature ejaculation. These substances are applied to the penis 10 to 15 minutes before sexual activity to reduce sensation and delay ejaculation.

·       Premature ejaculation (PE) is the most common sexual disorder among men, affecting an estimated 30% to 50% of the male population worldwide.

Thelansis’s “Premature Ejaculation (PE) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Premature Ejaculation (PE) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Premature Ejaculation (PE) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Premature Ejaculation (PE) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Premature Ejaculation (PE) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Comments

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Metabolic Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Type 1 Diabetes Mellitus (T1D) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033